The prevalence of side effects among participants in terms of demographic characteristics after first and second dose of AstraZeneca COVID-19 vaccine.

Post-vaccination side effects following the second dose of COVID-19 vaccine among health care workers

Timsi Jain
Balaji Selvaraju
Catherine Jude
Ganesan Dinesh Kumar
Yogesh Mohan
Anantha Eashwar

June 2022

The coronavirus disease 2019 (COVID-19) vaccines were launched after granting them ‘emergency use au...

Prevalence of the COVID-19 infection (percentage) before and after vaccination.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) prevalence of COVID-19 infection before, after one dose and after two doses of the Pfizer, Astra...

Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines:A Prospective Cohort Study

Zare, Zahra
Assarroudi, Abdolghader
Armat, Mohammad Reza
Laal Ahangar, Mojtaba
Estaji, Mahdie
MoghaddamHosseini, Vahideh
Dianatinasab, Mostafa

December 2022

UNLABELLED: The concern about post-COVID-19 vaccine complications still remains. In addition, the ev...

The prevalence of side effects among participants in terms of demographic characteristics after first and second dose of AstraZeneca COVID-19 vaccine.

Majid Eterafi (16450158)
Nasrin Fouladi (17743306)
Majid Golizadeh (17743309)
Hamidreza Shaker (16450155)
Somaieh Matin (9632042)
Elham Safarzadeh (10167320)

January 2024

The prevalence of side effects among participants in terms of demographic characteristics after firs...

Prevalence of the COVID-19 vaccines adverse effects (percentage) associated with various vaccine types (Pfizer, AstraZeneca and Sinopharm) among vaccinated participants.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) after the first dose, (B) after the second dose. A statistical analysis of the adverse effects a...

Prevalence of the adverse effects (percentage) associated with various vaccine types among vaccinated male and female participants.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) Pfizer after the first dose, (B) Pfizer after the second dose, (C) AstraZeneca after the first d...

Regression model for predicting general side effects in first or second dose of AstraZeneca vaccine.

Majid Eterafi (16450158)
Nasrin Fouladi (17743306)
Majid Golizadeh (17743309)
Hamidreza Shaker (16450155)
Somaieh Matin (9632042)
Elham Safarzadeh (10167320)

January 2024

Regression model for predicting general side effects in first or second dose of AstraZeneca vaccine....

Predictors associated with the COVID-19 infection status and side effects of vaccination among the respondents (n = 300).

Bilkis Banu (9153356)
Nasrin Akter (3619919)
Sujana Haque Chowdhury (12107161)
Kazi Rakibul Islam (12107164)
Md. Tanzeerul Islam (12107167)
Muhammad Zahangir (14123884)
Shah Monir Hossain (14123887)
Sarder Mahmud Hossain (12107170)

November 2022

Predictors associated with the COVID-19 infection status and side effects of vaccination among the r...

Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India

Md Anwarul Azim Majumder (13935069)
Keerti Singh (6708695)
WMS Johnson (16677933)
Archana Rajasundaram (16677936)
Subir Gupta (9322536)
Uma Gaur (3797884)
Santosh Kumar (106550)
Madhuri Chatterjee (476561)
Ahbab Mohammad Fazle Rabbi (16677939)
Vijay Prasad Sangishetti (16677942)
Sayeeda Rahman (13935057)
Michael H Campbell (16677945)
Heather Harewood (16677948)
Ambadasu Bharatha (6708698)
Kandamaran Krishnamurthy (13935054)
Russell Kabir (11014358)
Ali Davod Parsa (13935066)
Shegufta Mohammmad (16677951)
Mainul Haque (3485363)
Mohammed S Razzaque (16677954)

January 2023

Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines....

Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia

Abanoub Riad
Barbora Hocková
Lucia Kantorová
Rastislav Slávik
Lucia Spurná
Adam Stebel
Michal Havriľak
Miloslav Klugar

August 2021

mRNA-based COVID-19 vaccines such as BNT162b2 have recently been a target of anti-vaccination campai...

Evaluation of the Severity of Symptoms of AstraZeneca COVID-19 Vaccine After the First Dose in Western Libya

Fatima Alhaddad* , Khaleel Abuleid, Abojela Daw

February 2023

Background and aims. There have been numerous COVID-19 vaccines introduced with various efficacy and...

Evaluation of the Severity of Symptoms of AstraZeneca COVID-19 Vaccine After the First Dose in Western Libya

Fatima Alhaddad* , Khaleel Abuleid, Abojela Daw

February 2023

Background and aims. There have been numerous COVID-19 vaccines introduced with various efficacy and...

Adverse events related to vaccination description and proportion of volunteers suffering any side effects.

Alberto C. Guardo (3171261)
Carmen Elena Gómez (123013)
Vicens Díaz-Brito (4532425)
Judit Pich (4532434)
Joan Albert Arnaiz (4532440)
Beatriz Perdiguero (123011)
Juan García-Arriaza (207920)
Nuria González (4532422)
Carlos O. S. Sorzano (4045436)
Laura Jiménez (372190)
José Luis Jiménez (125164)
María Ángeles Muñoz-Fernández (4532437)
José M Gatell (4532428)
José Alcamí (79441)
Mariano Esteban (50256)
Juan Carlos López Bernaldo de Quirós (4532431)
Felipe García (111854)
Montserrat Plana (300247)

October 2017

<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...

Evaluation of adverse effects of AstraZeneca COVID-19 vaccine after the first dose in Libyan adults: a cross-sectional study

Fatima E. Alhaddad

December 2022

On January 2021, cases affected by coronavirus epidemic are constantly increasing, Libyan Ministry o...

Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study

Muhammad Nauman Zahid

November 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) created a global pandemic (COVID-19) th...

Post-vaccination side effects following the second dose of COVID-19 vaccine among health care workers

Timsi Jain
Balaji Selvaraju
Catherine Jude
Ganesan Dinesh Kumar
Yogesh Mohan
Anantha Eashwar

June 2022

The coronavirus disease 2019 (COVID-19) vaccines were launched after granting them ‘emergency use au...

Prevalence of the COVID-19 infection (percentage) before and after vaccination.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) prevalence of COVID-19 infection before, after one dose and after two doses of the Pfizer, Astra...

Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines:A Prospective Cohort Study

Zare, Zahra
Assarroudi, Abdolghader
Armat, Mohammad Reza
Laal Ahangar, Mojtaba
Estaji, Mahdie
MoghaddamHosseini, Vahideh
Dianatinasab, Mostafa

December 2022

UNLABELLED: The concern about post-COVID-19 vaccine complications still remains. In addition, the ev...

The prevalence of side effects among participants in terms of demographic characteristics after first and second dose of AstraZeneca COVID-19 vaccine.

Majid Eterafi (16450158)
Nasrin Fouladi (17743306)
Majid Golizadeh (17743309)
Hamidreza Shaker (16450155)
Somaieh Matin (9632042)
Elham Safarzadeh (10167320)

January 2024

The prevalence of side effects among participants in terms of demographic characteristics after firs...

Prevalence of the COVID-19 vaccines adverse effects (percentage) associated with various vaccine types (Pfizer, AstraZeneca and Sinopharm) among vaccinated participants.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) after the first dose, (B) after the second dose. A statistical analysis of the adverse effects a...

Prevalence of the adverse effects (percentage) associated with various vaccine types among vaccinated male and female participants.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) Pfizer after the first dose, (B) Pfizer after the second dose, (C) AstraZeneca after the first d...

Regression model for predicting general side effects in first or second dose of AstraZeneca vaccine.

Majid Eterafi (16450158)
Nasrin Fouladi (17743306)
Majid Golizadeh (17743309)
Hamidreza Shaker (16450155)
Somaieh Matin (9632042)
Elham Safarzadeh (10167320)

January 2024

Regression model for predicting general side effects in first or second dose of AstraZeneca vaccine....

Predictors associated with the COVID-19 infection status and side effects of vaccination among the respondents (n = 300).

Bilkis Banu (9153356)
Nasrin Akter (3619919)
Sujana Haque Chowdhury (12107161)
Kazi Rakibul Islam (12107164)
Md. Tanzeerul Islam (12107167)
Muhammad Zahangir (14123884)
Shah Monir Hossain (14123887)
Sarder Mahmud Hossain (12107170)

November 2022

Predictors associated with the COVID-19 infection status and side effects of vaccination among the r...

Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India

Md Anwarul Azim Majumder (13935069)
Keerti Singh (6708695)
WMS Johnson (16677933)
Archana Rajasundaram (16677936)
Subir Gupta (9322536)
Uma Gaur (3797884)
Santosh Kumar (106550)
Madhuri Chatterjee (476561)
Ahbab Mohammad Fazle Rabbi (16677939)
Vijay Prasad Sangishetti (16677942)
Sayeeda Rahman (13935057)
Michael H Campbell (16677945)
Heather Harewood (16677948)
Ambadasu Bharatha (6708698)
Kandamaran Krishnamurthy (13935054)
Russell Kabir (11014358)
Ali Davod Parsa (13935066)
Shegufta Mohammmad (16677951)
Mainul Haque (3485363)
Mohammed S Razzaque (16677954)

January 2023

Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines....

Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia

Abanoub Riad
Barbora Hocková
Lucia Kantorová
Rastislav Slávik
Lucia Spurná
Adam Stebel
Michal Havriľak
Miloslav Klugar

August 2021

mRNA-based COVID-19 vaccines such as BNT162b2 have recently been a target of anti-vaccination campai...

Evaluation of the Severity of Symptoms of AstraZeneca COVID-19 Vaccine After the First Dose in Western Libya

Fatima Alhaddad* , Khaleel Abuleid, Abojela Daw

February 2023

Background and aims. There have been numerous COVID-19 vaccines introduced with various efficacy and...

Evaluation of the Severity of Symptoms of AstraZeneca COVID-19 Vaccine After the First Dose in Western Libya

Fatima Alhaddad* , Khaleel Abuleid, Abojela Daw

February 2023

Background and aims. There have been numerous COVID-19 vaccines introduced with various efficacy and...

Adverse events related to vaccination description and proportion of volunteers suffering any side effects.

Alberto C. Guardo (3171261)
Carmen Elena Gómez (123013)
Vicens Díaz-Brito (4532425)
Judit Pich (4532434)
Joan Albert Arnaiz (4532440)
Beatriz Perdiguero (123011)
Juan García-Arriaza (207920)
Nuria González (4532422)
Carlos O. S. Sorzano (4045436)
Laura Jiménez (372190)
José Luis Jiménez (125164)
María Ángeles Muñoz-Fernández (4532437)
José M Gatell (4532428)
José Alcamí (79441)
Mariano Esteban (50256)
Juan Carlos López Bernaldo de Quirós (4532431)
Felipe García (111854)
Montserrat Plana (300247)

October 2017

<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...

Evaluation of adverse effects of AstraZeneca COVID-19 vaccine after the first dose in Libyan adults: a cross-sectional study

Fatima E. Alhaddad

December 2022

On January 2021, cases affected by coronavirus epidemic are constantly increasing, Libyan Ministry o...

Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study

Muhammad Nauman Zahid

November 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) created a global pandemic (COVID-19) th...

Post-vaccination side effects following the second dose of COVID-19 vaccine among health care workers

Timsi Jain
Balaji Selvaraju
Catherine Jude
Ganesan Dinesh Kumar
Yogesh Mohan
Anantha Eashwar

June 2022

The coronavirus disease 2019 (COVID-19) vaccines were launched after granting them ‘emergency use au...

Prevalence of the COVID-19 infection (percentage) before and after vaccination.

Omeed Darweesh (14141829)
Nasir Khatab (14141832)
Ramiar Kheder (7781564)
Thulfiqar Mohammed (14141835)
Tola Faraj (14141838)
Sabah Ali (14141841)
Muath Ameen (14141844)
Azad Kamal-Aldin (14141847)
Mohammed Alswes (14141850)
Naif Al-Jomah (9118583)

November 2022

(A) prevalence of COVID-19 infection before, after one dose and after two doses of the Pfizer, Astra...

Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines:A Prospective Cohort Study

Zare, Zahra
Assarroudi, Abdolghader
Armat, Mohammad Reza
Laal Ahangar, Mojtaba
Estaji, Mahdie
MoghaddamHosseini, Vahideh
Dianatinasab, Mostafa

December 2022

UNLABELLED: The concern about post-COVID-19 vaccine complications still remains. In addition, the ev...

The prevalence of side effects among participants in terms of demographic characteristics after first and second dose of AstraZeneca COVID-19 vaccine.

Abstract

Extracted data

The prevalence of side effects among participants in terms of demographic characteristics after first and second dose of AstraZeneca COVID-19 vaccine.

Abstract

Extracted data

Related items

Related items